Listen to insights on haematology data, as discussed by experts in the field
Listen to Dr William Townsend and Dr Wendy Osborne discuss the GALLIUM 4-year follow-up results, and the clinical relevance of endpoints.
A discussion including Prof Russell Patmore, Dr Wendy Osborne and
Dr Graham Collins exploring the findings from the retrospective sub-analysis of the GALLIUM study in patients with FLIPI scores ≥2.
Listen to Prof. Andrew Davies discuss FAQs about GALLIUM, including the study design and efficacy vs safety.
Coming soon – listen to Dr Wendy Osborne discuss PET, MRD and the relevance of having no evidence of active disease for patients.
Coming soon – Dr Wendy Osborne discusses chemotherapy backbones and their role in FL.
1L, first-line; CLL, chronic lymphocytic leukaemia; FAQs, frequently asked questions; FL, follicular lymphoma; FLIPI, Follicular Lymphoma International Prognostic Index; MRD, minimal residual disease; PET, positron emission tomography.
Date of preparation: November 2019